Production of Plasminogen Activators by HTLV-Transformed T Cell Lines
Author Information
Author(s): S. Hinumal, S. Honda, K. Tsukamotol, K. Sugamura, Y. Hinuma
Primary Institution: Biotechnology Laboratories, Central Research Division, Takeda Chemical Industries, Ltd.
Hypothesis
Do HTLV-transformed T cell lines produce plasminogen activators in varying amounts and types?
Conclusion
HTLV-transformed T cell lines produce plasminogen activators that are heterogeneous in both quality and quantity.
Supporting Evidence
- All six HTLV-transformed T cell lines produced plasminogen activators.
- KAN produced the highest amount of plasminogen activator, while TCL-Mor produced the lowest.
- HTLV-negative cell lines did not produce detectable amounts of plasminogen activators.
- Different cell lines produced different types of plasminogen activators, including UK-type and non-UK-type.
Takeaway
Some special cells from people with a virus can make substances that help break down blood clots, and different types of these cells make different amounts.
Methodology
The study involved culturing six HTLV-transformed T cell lines and measuring the plasminogen activator activity in their culture supernatants.
Participant Demographics
The cell lines were derived from human peripheral blood leucocytes, including healthy HTLV-carriers.
Want to read the original?
Access the complete publication on the publisher's website